Cargando…

Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients

OBJECTIVE: To evaluate the oncologic outcomes of adjuvant chemotherapy (CT) alone after radical surgery. METHODS: We retrospectively reviewed the medical records of patients who underwent type C radical hysterectomy and pelvic lymphadenectomy with or without paraaortic lymphadenectomy for stage IB–I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kwang-Beom, Kim, Young Saing, Lee, Jong-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709531/ https://www.ncbi.nlm.nih.gov/pubmed/29185263 http://dx.doi.org/10.3802/jgo.2018.29.e5

Ejemplares similares

Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting
por: Jung, Phill-Seung, et al.
Publicado: (2015)

Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer
por: Huang, Yuhui, et al.
Publicado: (2022)

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)
por: Katsumata, N, et al.
Publicado: (2013)

Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
por: Zhou, Fang, et al.
Publicado: (2022)

Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)'
por: Nagano, H
Publicado: (2013)

Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis
por: Lee, Kwang-Beom, et al.
Publicado: (2018)

Reply: ‘Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)'
por: Katsumata, N
Publicado: (2013)

Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study
por: Sun, Hai-Yan, et al.
Publicado: (2018)

Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update
por: Landoni, Fabio, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis
por: Li, Weili, et al.
Publicado: (2021)

Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)
por: Akhavan, Setareh, et al.
Publicado: (2021)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
por: Zhang, Pei, et al.
Publicado: (2020)

The Effect of Neoadjuvant Chemotherapy Combined With Brachytherapy Before Radical Hysterectomy on Stage IB2 and IIA Cervical Cancer: A Retrospective Analysis
por: Dang, Yun, et al.
Publicado: (2021)

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery
por: Zhang, Xiaojing, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis
por: Ye, Qingjian, et al.
Publicado: (2020)

Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study
por: Zhao, Hui, et al.
Publicado: (2019)

Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery?
por: Lee, Seung-Ho, et al.
Publicado: (2018)

Neoadjuvant chemotherapy combined with radical surgery for stage IB2/IIA2 cervical squamous cell carcinoma: a prospective, randomized controlled study of 35 patients
por: Jing, Huang, et al.
Publicado: (2021)

Monocytosis as a prognostic factor for survival in stage IB and IIA cervical cancer
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
por: Park, Jeong-Yeol, et al.
Publicado: (2012)

Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB-IIA node negative uterine cervical cancer after radical hysterectomy and trachelectomy
por: Kinjo, Yasuyuki, et al.
Publicado: (2022)

Comparison of survival outcomes between radical hysterectomy and definitive radiochemotherapy in stage IB1 and IIA1 cervical cancer
por: Wu, San-Gang, et al.
Publicado: (2017)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes
por: Yang, Eun Jung, et al.
Publicado: (2022)

Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery
por: Sun, Haiying, et al.
Publicado: (2018)

Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1–IIa cervical cancer patients who undergo radical surgery
por: Chen, Liang, et al.
Publicado: (2015)

PET/CT imaging analysis of recurrent sites and patterns of spread following modified radical surgery (type B) for stage Ib-IIa cervical cancer
por: Cheng, Shuxia, et al.
Publicado: (2018)

Outcome evaluation of neoadjuvant chemotherapy in patients with stage IB2 or IIA cervical cancer: a retrospective comparative study
por: Yan, Wenxing, et al.
Publicado: (2020)

Comparison of Oncologic Outcomes between Radical Hysterectomy and Primary Concurrent Chemoradiotherapy in Women with Bulky IB and IIA Cervical Cancer under Risk Stratification
por: Chen, Chung-Shih, et al.
Publicado: (2023)

Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
por: Gaffney, David K.
Publicado: (2012)

Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
por: Marchetti, Claudia, et al.
Publicado: (2018)

Fertility-sparing management of a stage IB1 small cell neuroendocrine cervical carcinoma with radical abdominal trachelectomy and adjuvant chemotherapy
por: Singh, Sareena, et al.
Publicado: (2015)

Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2
por: Choi, Yae Ji, et al.
Publicado: (2021)

Vaginal cuff length during radical hysterectomy is a prognostic factor for stage IB-IIA cervical cancer: a retrospective study
por: Zuo, Na, et al.
Publicado: (2018)

Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study
por: Ishizawa, Chihiro, et al.
Publicado: (2023)

A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy
por: Jang, Tae-Kyu, et al.
Publicado: (2017)

Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals
por: Liu, Ping, et al.
Publicado: (2020)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery
por: Miller, Heather, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fbjfipe9i557ko0gtipgfqlb12